Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:30 PM ET Form 4
Insider Selling Dell Technologies Inc. DELL

Dell Technologies Director Silver Lake Partners V DE (AIV) L.P. Sells $15.3M of Stock

Silver Lake Partners V DE (AIV) L.P., Director, sold 26,539 shares of Dell Technologies Inc. at $571.90 to $580.76 a share (average $575.43) in 11 transactions, worth $15.3M in total on Oct 6, 2026. Shares held after the trade: 12,246 (-11.6%).

Value
$15.3M
Shares
26,539
Average price
$575.43
Role
Director
Holding change
-11.6%
Trade date
Oct 6, 2026
4:30 PM ET 8-K
M&A Deal Calisa Acquisition Corp ALIS

Calisa Acquisition M&A Deal with Goodvision AI Inc.

Calisa Acquisition Corp held an extraordinary general meeting where shareholders approved the Business Combination Agreement with Goodvision AI Inc. The transaction includes a merger where Goodvision will become a wholly owned subsidiary of the company, which will be renamed Goodvision AI Holding Limited. Shareholders also approved the issuance of shares for the deal and a redesignation of the company's authorized share capital.

Counterparty
Goodvision AI Inc.
4:30 PM ET Form 4
Insider Buying Corebridge Financial, Inc. CRBG

Corebridge Financial 10% Owner Nippon Life Insurance Co Buys $4.1M of Stock

Nippon Life Insurance Co, 10% Owner, bought 116,345 shares of Corebridge Financial, Inc. at $35.23 a share, worth $4.1M in total on Oct 6, 2026. Shares held after the trade: 126,786,106 (+0.1%).

Value
$4.1M
Shares
116,345
Price
$35.23
Role
10% Owner
Holding change
+0.1%
Trade date
Oct 6, 2026
4:30 PM ET Form 4
Insider Selling Dell Technologies Inc. DELL

Dell Technologies Director Silver Lake Technology Investors IV L.P. Sells $580K of Stock

Silver Lake Technology Investors IV L.P., Director, sold 1,009 shares of Dell Technologies Inc. at $571.90 to $579.63 a share (average $575.30) in 9 transactions, worth $580K in total on Oct 6, 2026. Shares held after the trade: 27 (-70.0%).

Value
$580K
Shares
1,009
Average price
$575.30
Role
Director
Holding change
-70.0%
Trade date
Oct 6, 2026
4:30 PM ET Form 4
Insider Selling Dell Technologies Inc. DELL

Dell Technologies Director Silver Lake Technology Investors V L.P. Sells $262K of Stock

Silver Lake Technology Investors V L.P., Director, sold 455 shares of Dell Technologies Inc. at $571.90 to $579.63 a share (average $575.31) in 9 transactions, worth $262K in total on Oct 6, 2026. Shares held after the trade: 12 (-70.0%).

Value
$262K
Shares
455
Average price
$575.31
Role
Director
Holding change
-70.0%
Trade date
Oct 6, 2026
4:30 PM ET Form 4
Insider Selling Dell Technologies Inc. DELL

Dell Technologies Director Sl SPV-2 L.P. Sells $26.7M of Stock

Sl SPV-2 L.P., Director, sold 46,323 shares of Dell Technologies Inc. at $571.90 to $580.76 a share (average $575.43) in 11 transactions, worth $26.7M in total on Oct 6, 2026. Shares held after the trade: 23,439 (-10.7%).

Value
$26.7M
Shares
46,323
Average price
$575.43
Role
Director
Holding change
-10.7%
Trade date
Oct 6, 2026
4:29 PM ET Form 4
Insider Selling Analog Devices Inc ADI

Analog Devices Insider Ray Stata Sells $1.17M of Stock

Ray Stata sold 2,832 shares of Analog Devices Inc at $405.57 to $421.24 a share (average $413.71) in 11 transactions, worth $1.17M in total between Oct 6, 2026 and Oct 7, 2026. Shares held after the trade: 107,457 (-0.1%).

Value
$1.17M
Shares
2,832
Average price
$413.71
Holding change
-0.1%
Trade date
Oct 6, 2026 to Oct 7, 2026
4:27 PM ET 8-K
Financial Results Park Aerospace Corp PKE

Park Aerospace Financial Results

Park Aerospace Corp. reported financial results for its 2027 fiscal year second quarter ended August 30, 2026, with net sales increasing to $20.8 million from $16.4 million in the prior year's second quarter. Net earnings for the quarter rose significantly to $4.5 million, or $0.21 per share, compared to $2.4 million, or $0.12 per share, in the same period last year.

Term
Q2 2027
Earnings call
Oct 15, 2026, 5:00 PM ET
4:19 PM ET 8-K
Loan & Debt Hercules Capital, Inc. HTGC

Hercules Capital $400M Debt Financing with U.S. Bank Trust Company, National Association

Hercules Capital, Inc. completed the issuance and sale of $400 million in aggregate principal amount of 6.700% Notes due 2029. The notes are unsecured senior obligations maturing on October 8, 2029, and were issued under a Twelfth Supplemental Indenture with U.S. Bank Trust Company as trustee.

Value
$400M
Counterparty
U.S. Bank Trust Company, National Association
Term
3 years
4:19 PM ET 8-K
Business Update Brookdale Senior Living Inc. BKD

Brookdale Senior Living Business Update

Brookdale Senior Living reported its September 2026 occupancy metrics, showing a consolidated weighted average occupancy of 83.4% and a month-end occupancy of 84.6%. For the full third quarter of 2026, weighted average consolidated occupancy grew 130 basis points year-over-year to 83.1%, outperforming sequential market trends reported by the National Investment Center for Seniors Housing & Care.

Term
September 2026
4:19 PM ET 8-K
Divestiture Devon Energy Corp DVN

Devon Energy Divestiture to Crescent Energy Company for $4.2B

Devon Energy has entered into a definitive agreement to sell its Eagle Ford assets in South Texas to Crescent Energy Company for $4.2 billion in cash. The divestiture includes approximately 90,000 net acres and is intended to high-grade Devon's portfolio while providing proceeds to accelerate share repurchases and debt reduction.

Value
$4.2B
Counterparty
Crescent Energy Company
4:17 PM ET 8-K
Business Update EOG Resources Inc EOG

EOG Resources Business Update

EOG Resources updated its Q3 2026 guidance for current tax expense to a range of $835 million - $935 million, up from the previous forecast of $545 million - $645 million. The increase is driven by higher realized crude oil prices resulting from ongoing conflict in the Middle East. The company also reported receiving $40 million in net cash from commodity derivative settlements during the third quarter.

Term
Q3 2026
4:16 PM ET 8-K
Investor Presentation Tenax Therapeutics, Inc. TENX

Tenax Therapeutics Investor Presentation

Tenax Therapeutics filed an updated investor presentation detailing strategic changes to its Phase 3 LEVEL-2 clinical trial for TNX-103 in PH-HFpEF. The company is pausing enrollment to amend protocol criteria based on findings from its completed LEVEL trial and has requested a Type C meeting with the FDA to discuss the development path.

4:16 PM ET 8-K
Leadership Change Gartner Inc IT

Gartner Leadership Change

Thomas Kim, Executive Vice President, Chief Legal Officer & Secretary of Gartner, Inc., notified the company on October 3, 2026, that he will be stepping down effective October 16, 2026. Mr. Kim is leaving to pursue a new senior executive opportunity, and the company stated there were no disagreements regarding financials or operations.

4:15 PM ET Form 4
Insider Selling Oklo Inc. OKLO

Oklo General Counsel & Secretary Vivek Narayanadas Sells $10.7K of Stock

Vivek Narayanadas, General Counsel & Secretary, sold 288 shares of Oklo Inc. at $37.29 a share, worth $10.7K in total on Oct 6, 2026. Shares held after the trade: 8,446 (-3.3%).

Value
$10.7K
Shares
288
Price
$37.29
Role
General Counsel & Secretary
Holding change
-3.3%
Trade date
Oct 6, 2026
4:14 PM ET 8-K
Leadership Change Aardvark Therapeutics, Inc. AARD

Aardvark Therapeutics Leadership Change

Aardvark Therapeutics appointed David (Zhongwei) Zhang, Ph.D., MBA, as a Class II director to its Board of Directors, effective October 7, 2026. Dr. Zhang brings over 25 years of experience in clinical strategy and biostatistics from roles at Abivax, Alumis, and MyoKardia. As a non-employee director, he will receive an annual cash retainer of $40,000 and an initial stock option grant valued at $500,000.

4:13 PM ET Form 4
Insider Selling Appian Corp APPN

Appian CEO and President Matthew W. Calkins Sells $1.69M of Stock

Matthew W. Calkins, CEO and President, sold 45,000 shares of Appian Corp at $37.32 to $37.97 a share (average $37.50) in 2 transactions, worth $1.69M in total on Oct 7, 2026. Shares held after the trade: 1,584,144 (-0.8%).

Value
$1.69M
Shares
45,000
Average price
$37.50
Role
CEO and President
Holding change
-0.8%
Trade date
Oct 7, 2026
4:13 PM ET 8-K
Financial Results Oil-Dri Corp of America ODC

Oil-Dri Corp of America Financial Results

Oil-Dri Corporation of America reported record annual net sales of $493.8 million and record net income of $57.0 million for fiscal year 2026. The company also declared quarterly cash dividends of $0.225 per share of Common Stock and $0.168 per share of Class B Stock, and appointed Anthony W. Parker as an executive officer.

Term
FY2026

“Fiscal year 2026 has been especially meaningful as we celebrated our 85th anniversary and reported our strongest full-year sales and net income in history. In the first half of the year, we faced difficult comparisons against a robust prior period. Our team remained focused on growing the business in the second half and ultimately delivered solid results that surpassed last year’s performance. The fourth quarter closed out the year on a high note, with record breaking sales.”

Daniel S. Jaffee, President and Chief Executive Officer
4:12 PM ET 8-K
Business Update Quantum-Si Inc QSI

Quantum-Si Business Update

Quantum-Si announced it has successfully demonstrated the detection of 19 amino acids within its Proteus development program, a key technical milestone for its single-molecule protein sequencing platform. The company remains on track to demonstrate detection of all 20 amino acids by the end of 2026 and expects a commercial launch of the Proteus platform in the second quarter of 2027.

4:12 PM ET Form 4
Insider Selling Trane Technologies plc TT

Trane Technologies Chair and CEO David S. Regnery Sells $23.1M of Stock

David S. Regnery, Chair and CEO, sold 48,091 shares of Trane Technologies plc at $480.00 a share, worth $23.1M in total on Oct 6, 2026. Shares held after the trade: 96,951 (-33.2%).

Value
$23.1M
Shares
48,091
Price
$480.00
Role
Chair and CEO
Holding change
-33.2%
Trade date
Oct 6, 2026
4:10 PM ET 8-K
Stock Buyback Calix, Inc CALX

Calix Announces $100M Stock Buyback

Calix, Inc. announced that its board of directors has authorized an additional $100 million for its existing stock repurchase program. The increase is intended to provide greater flexibility for the company's capital allocation strategy, allowing for repurchases through open market or private transactions based on market conditions.

Value
$100M
4:09 PM ET 8-K
M&A Deal StageWise Strategies Corp. TEGO

StageWise Strategies M&A Deal with Teg SPV LLC

StageWise Strategies Corp. entered into a definitive Share Exchange Agreement to acquire 99.99% of TEG SPV LLC, an Uzbekistan-based entity, from Tourism and Entertainment Group LLC and an individual seller. In exchange, the company will issue 183,098,434 shares of common stock, representing approximately 97.3% of the post-transaction outstanding shares. Upon closing, TEG SPV will become a subsidiary and its operations will become the principal business of the company.

Counterparty
TEG SPV LLC
4:08 PM ET 8-K
Investor Presentation Braemar Hotels & Resorts Inc. BHR

Braemar Hotels & Resorts Investor Presentation

Braemar Hotels & Resorts announced a definitive agreement to sell the Four Seasons Resort Scottsdale for $372 million as part of its strategic transition to a self-managed REIT. The company also released a comprehensive investor presentation titled 'A New Chapter for Braemar' and provided a 2027 financial outlook following its separation from Ashford Inc.

4:08 PM ET Form 4
Insider Selling Pacific Biosciences of California, Inc. PACB

Pacific Biosciences of California Insider James R. Gibson II Sells $2.06M of Stock

James R. Gibson II sold 661,815 shares of Pacific Biosciences of California, Inc. at $3.11 a share, worth $2.06M in total on Oct 6, 2026. Shares held after the trade: 1,083,848 (-37.9%).

Value
$2.06M
Shares
661,815
Price
$3.11
Holding change
-37.9%
Trade date
Oct 6, 2026
4:07 PM ET Form 4
Insider Selling Rapport Therapeutics, Inc. RAPP

Rapport Therapeutics CEO Abraham Ceesay Sells $143K of Stock

Abraham Ceesay, CEO, sold 4,522 shares of Rapport Therapeutics, Inc. at $30.66 to $32.03 a share (average $31.68) in 2 transactions, worth $143K in total between Oct 6, 2026 and Oct 7, 2026. Shares held after the trade: 452,245 (-0.3%).

Value
$143K
Shares
4,522
Average price
$31.68
Role
CEO
Holding change
-0.3%
Trade date
Oct 6, 2026 to Oct 7, 2026
4:07 PM ET Form 4
Insider Selling Everpure, Inc. P

Everpure Insider Mallun Yen Sells $1.76M of Stock

Mallun Yen sold 11,942 shares of Everpure, Inc. at $145.95 to $148.55 a share (average $146.97) in 4 transactions, worth $1.76M in total on Oct 6, 2026. Shares held after the trade: 31,339 (-0.9%).

Value
$1.76M
Shares
11,942
Average price
$146.97
Holding change
-0.9%
Trade date
Oct 6, 2026
4:07 PM ET 8-K
Leadership Change KiNRG, Inc. BYOP

KiNRG Leadership Change

Robert P. Crabb resigned as Secretary of KiNRG, Inc. effective October 2, 2026. Stephen Sadle, the company's current Chief Operating Officer and director, was appointed as the new Secretary to replace him.

4:07 PM ET 8-K
Loan & Debt Werner Enterprises Inc WERN

Werner Enterprises $1.1B Debt Financing with BMO Bank, N.A.

Werner Enterprises entered into a new $1.1 billion unsecured credit facility maturing in October 2031, replacing its previous $1.075 billion facility. The company immediately borrowed $465 million under the new agreement at a weighted average interest rate of 5.54% to refinance existing debt and for general corporate purposes. The new agreement eliminates the 0.10% SOFR credit adjustment spread present in the prior 2022 facility.

Value
$1.1B
Counterparty
BMO Bank, N.A.
Term
5 years
4:06 PM ET 8-K
Loan & Debt Vireo Growth Inc. VREOF

Vireo Growth $60M Debt Financing with Needham Bank

Vireo Growth Inc. entered into a $60 million term loan agreement with Needham Bank at a fixed interest rate of 8.50% per annum. The proceeds were used to refinance $49 million of existing senior debt related to its New York cultivation facility and to finance the $11 million acquisition of its Palatka, Florida cultivation facility. The loan is secured by first-priority mortgages on these properties and matures in April 2034.

Value
$60M
Counterparty
Needham Bank
Term
through April 2, 2034

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.